KPRX
Kiora Pharmaceuticals, Inc. Common Stock
stockNASDAQ
traded on nasdaq capital market, stock symbol eyeg, eyegate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye. our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid ("cmha-s"), a modified form of the natural polymer hyaluronic acid ("ha"), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface. our first cmha-s-based product candidate, the eyegate ocular bandage gel ("obg"), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy ("prk") surgery. our initial product candidate from our second platform is egp-437, incorporates a reformulated topically active corticosteroid, dexamethasone
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 2.67 | 2026-09-28 | -3.75% | 1.561 |
| 1M | 2.55 | 2026-09-04 | +0.78% | 0.131 |
| 3M | 2.55 | 2026-07-06 | +0.78% | -0.354 |
| 6M | 2.02 | 2026-04-06 | +27.23% | 0.915 |
| 1Y | 2.75 | 2025-10-03 | -6.54% | 0.977 |
| 2Y | 3.46 | 2024-10-04 | -25.61% | — |
| 5Y | 655.20 | 2021-10-04 | -99.61% | 0.869 |
Kiora Pharmaceuticals, Inc. Common Stock (NASDAQ:KPRX) stock price today is $2.57, and today's volume is 3,437. KPRX is down 0.388% today. The 30 day average volume is 13,375. KPRX market cap is $11.37M with 4.42M shares outstanding.